TBPH Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $563,800.00

Theravance Biopharma Insider Trading History Chart

Theravance Biopharma Share Price & Price History

^$18.70

▼ -0.19 (-1.01%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Theravance Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/14/2025	Rhonda Farnum	SVP	Sell	10,000	$11.39	$113,900.00	326,918
7/14/2025	Rhonda Farnum	SVP	Sell	10,000	$11.39	$113,900.00	326,918
6/2/2025	Rhonda Farnum	SVP	Sell	24,000	$11.00	$264,000.00	336,918
4/21/2025	Rhonda Farnum	SVP	Sell	4,000	$9.00	$36,000.00	370,038
1/21/2025	Rhonda Farnum	SVP	Sell	4,000	$9.00	$36,000.00	309,565
11/11/2024	Rhonda Farnum	SVP	Sell	4,000	$9.00	$36,000.00	322,743
8/7/2024	Eli Samaha	Major Shareholder	Buy	999,800	$7.80	$7,798,440.00	9,511,150
7/10/2024	Rhonda Farnum	SVP	Sell	4,000	$9.00	$36,000.00	335,965
2/22/2024	Rhonda Farnum	SVP	Sell	1,254	$8.71	$10,922.34	311,733
11/21/2023	Rhonda Farnum	SVP	Sell	1,378	$10.29	$14,179.62	331,206
11/14/2023	Richard A Graham	SVP	Sell	2,482	$10.22	$25,366.04	346,839
10/16/2023	Richard A Graham	SVP	Sell	2,482	$9.03	$22,412.46	334,321
9/14/2023	Richard A Graham	SVP	Sell	2,482	$9.89	$24,546.98	336,803
8/22/2023	Rhonda Farnum	SVP	Sell	1,807	$9.47	$17,112.29	340,566
8/11/2023	Richard A Graham	SVP	Sell	2,322	$9.99	$23,196.78	349,746
7/14/2023	Richard A Graham	SVP	Sell	2,322	$9.84	$22,848.48	352,068
6/14/2023	Richard A Graham	SVP	Sell	2,322	$10.69	$24,822.18	354,390
6/8/2023	Rhonda Farnum	SVP	Sell	1,790	$11.13	$19,922.70	352,833
5/15/2023	Richard A Graham	SVP	Sell	2,322	$11.26	$26,145.72	367,172
4/14/2023	Richard A Graham	SVP	Sell	2,323	$11.88	$27,597.24	369,494
3/14/2023	Richard A Graham	SVP	Sell	2,323	$10.32	$23,973.36	371,817
3/9/2023	Rhonda Farnum	SVP	Sell	4,000	$10.20	$40,800.00	360,190
3/6/2023	Richard A Graham	SVP	Sell	2,323	$10.05	$23,346.15	374,140
12/14/2022	Rick E Winningham	CEO	Sell	50,000	$11.19	$559,500.00	1,350,797
12/1/2022	Richard A Graham	SVP	Sell	2,084	$10.73	$22,361.32	313,520

SEC Filings (Institutional Ownership Changes) for Theravance Biopharma (NASDAQ:TBPH)

99.10% of Theravance Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Theravance Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/24/2025	CIBC Private Wealth Group LLC	4,685	$68K	0.0%	+20,269.6%	0.009%
11/21/2025	CIBC Bancorp USA Inc.	10,223	$0.15M	0.0%	N/A	0.020%
11/19/2025	Caitong International Asset Management Co. Ltd	2,725	$40K	0.0%	+107.4%	0.005%
11/17/2025	Jacobs Levy Equity Management Inc.	40,538	$0.59M	0.0%	+100.9%	0.080%
11/17/2025	PharVision Advisers LLC	10,751	$0.16M	0.1%	N/A	0.021%
11/17/2025	Sherbrooke Park Advisers LLC	12,189	$0.18M	0.1%	N/A	0.024%
11/17/2025	Quarry LP	1,776	$26K	0.0%	N/A	0.004%
11/17/2025	Qube Research & Technologies Ltd	211,048	$3.08M	0.0%	+2.8%	0.417%
11/17/2025	Park West Asset Management LLC	1,284,081	$18.75M	1.6%	-28.6%	2.534%
11/17/2025	Numerai GP LLC	28,232	$0.41M	0.1%	N/A	0.056%
11/17/2025	Millennium Management LLC	24,492	$0.36M	0.0%	-44.1%	0.048%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	37,611	$0.55M	0.0%	-3.7%	0.074%
11/17/2025	Jain Global LLC	20,204	$0.30M	0.0%	N/A	0.040%
11/17/2025	Citadel Advisors LLC	50,867	$0.74M	0.0%	-89.5%	0.100%
11/17/2025	Bank of America Corp DE	527,107	$7.70M	0.0%	-2.3%	1.040%
11/17/2025	Aquatic Capital Management LLC	16,768	$0.25M	0.0%	-53.7%	0.033%
11/17/2025	Algert Global LLC	199,705	$2.92M	0.0%	N/A	0.394%
11/14/2025	Creative Planning	13,450	$0.20M	0.0%	+6.7%	0.027%
11/14/2025	Man Group plc	79,791	$1.17M	0.0%	N/A	0.158%
11/14/2025	Two Sigma Investments LP	231,272	$3.38M	0.0%	+1,199.9%	0.459%
11/14/2025	Squarepoint Ops LLC	46,750	$0.68M	0.0%	+250.9%	0.093%
11/13/2025	Arrowstreet Capital Limited Partnership	726,783	$10.61M	0.0%	N/A	1.443%
11/13/2025	UBS Group AG	514,170	$7.51M	0.0%	+29.5%	1.021%
11/13/2025	BNP Paribas Financial Markets	373,600	$5.46M	0.0%	-3.6%	0.742%
11/13/2025	Franklin Resources Inc.	92,427	$1.35M	0.0%	+158.1%	0.184%
11/13/2025	Vestcor Inc	9,591	$0.14M	0.0%	N/A	0.019%
11/13/2025	WINTON GROUP Ltd	76,542	$1.12M	0.0%	N/A	0.152%
11/13/2025	Russell Investments Group Ltd.	5,062	$74K	0.0%	-88.1%	0.010%
11/12/2025	Barclays PLC	115,391	$1.69M	0.0%	-12.5%	0.229%
11/12/2025	Integrated Quantitative Investments LLC	25,172	$0.37M	0.1%	N/A	0.050%
11/12/2025	Dimensional Fund Advisors LP	766,704	$11.19M	0.0%	+6.2%	1.522%
11/12/2025	Quantbot Technologies LP	26,514	$0.39M	0.0%	N/A	0.053%
11/12/2025	Intech Investment Management LLC	22,676	$0.33M	0.0%	-15.0%	0.045%
11/10/2025	Hillsdale Investment Management Inc.	310,700	$4.54M	0.1%	N/A	0.617%
11/10/2025	China Universal Asset Management Co. Ltd.	8,828	$0.13M	0.0%	-12.1%	0.018%
11/7/2025	GSA Capital Partners LLP	92,181	$1.35M	0.1%	-33.2%	0.183%
11/7/2025	Vanguard Group Inc.	2,211,582	$32.29M	0.0%	+2.5%	4.392%
11/7/2025	JPMorgan Chase & Co.	213,104	$3.11M	0.0%	+78.3%	0.423%
11/6/2025	Rhumbline Advisers	55,643	$0.81M	0.0%	-2.9%	0.110%
11/6/2025	Baader Bank Aktiengesellschaft	53,500	$0.78M	0.1%	N/A	0.106%
11/5/2025	Alps Advisors Inc.	24,214	$0.35M	0.0%	-10.3%	0.048%
11/4/2025	State of Wyoming	30,752	$0.45M	0.1%	+62.5%	0.061%
10/30/2025	Strs Ohio	44,100	$0.64M	0.0%	N/A	0.088%
10/28/2025	Campbell & CO Investment Adviser LLC	52,617	$0.77M	0.1%	+4.4%	0.104%
10/23/2025	SG Americas Securities LLC	6,938	$0.10M	0.0%	N/A	0.014%
10/22/2025	Longboard Asset Management LP	13,102	$0.19M	0.3%	N/A	0.026%
10/15/2025	Inspire Investing LLC	73,556	$1.07M	0.1%	N/A	0.146%
10/7/2025	Assenagon Asset Management S.A.	414,715	$6.06M	0.0%	+1,629.4%	0.823%
8/19/2025	State of Wyoming	18,928	$0.21M	0.0%	+5.7%	0.038%
8/15/2025	Tower Research Capital LLC TRC	5,013	$55K	0.0%	+18.5%	0.010%
8/15/2025	Rangeley Capital LLC	33,729	$0.37M	0.5%	N/A	0.067%
8/15/2025	Oxford Asset Management LLP	14,429	$0.16M	0.1%	N/A	0.029%
8/15/2025	Militia Capital Partners LP	54,200	$0.60M	0.3%	N/A	0.108%
8/15/2025	Engineers Gate Manager LP	13,657	$0.15M	0.0%	N/A	0.027%
8/15/2025	BNP Paribas Financial Markets	387,472	$4.27M	0.0%	+30.8%	0.775%
8/15/2025	Bank of America Corp DE	539,645	$5.95M	0.0%	+16.5%	1.079%
8/14/2025	PDT Partners LLC	120,327	$1.33M	0.1%	+35.8%	0.241%
8/14/2025	Jane Street Group LLC	42,764	$0.47M	0.0%	-69.6%	0.086%
8/14/2025	Camber Capital Management LP	450,000	$4.96M	0.5%	-55.0%	0.900%
8/14/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	39,046	$0.43M	0.0%	-3.2%	0.078%
8/14/2025	The Manufacturers Life Insurance Company	15,747	$0.17M	0.0%	+6.9%	0.031%
8/14/2025	Qube Research & Technologies Ltd	205,280	$2.26M	0.0%	+80.2%	0.411%
8/13/2025	Jump Financial LLC	79,074	$0.87M	0.0%	N/A	0.158%
8/13/2025	Marshall Wace LLP	100,778	$1.11M	0.0%	+575.9%	0.202%
8/13/2025	Walleye Capital LLC	34,659	$0.38M	0.0%	N/A	0.069%
8/13/2025	Invesco Ltd.	25,324	$0.28M	0.0%	+12.4%	0.051%
8/13/2025	Virtus Investment Advisers LLC	41,884	$0.46M	0.2%	+15.1%	0.084%
8/13/2025	Hsbc Holdings PLC	57,214	$0.64M	0.0%	N/A	0.114%
8/13/2025	Russell Investments Group Ltd.	42,491	$0.47M	0.0%	-11.6%	0.085%
8/12/2025	Jefferies Financial Group Inc.	276,887	$3.05M	0.0%	+1,191.9%	0.554%
8/12/2025	American Century Companies Inc.	91,501	$1.01M	0.0%	+6.8%	0.183%
8/12/2025	Rhumbline Advisers	57,308	$0.63M	0.0%	-7.9%	0.115%
8/12/2025	JPMorgan Chase & Co.	119,513	$1.32M	0.0%	-23.8%	0.239%
8/8/2025	Intech Investment Management LLC	26,690	$0.29M	0.0%	-19.8%	0.053%
8/8/2025	Creative Planning	12,608	$0.14M	0.0%	N/A	0.025%
8/8/2025	Geode Capital Management LLC	893,983	$9.86M	0.0%	+0.4%	1.788%
8/7/2025	Acadian Asset Management LLC	308,652	$3.40M	0.0%	+76.8%	0.617%
8/7/2025	Campbell & CO Investment Adviser LLC	50,392	$0.56M	0.0%	N/A	0.101%
8/7/2025	Connor Clark & Lunn Investment Management Ltd.	56,613	$0.62M	0.0%	N/A	0.113%
8/7/2025	Los Angeles Capital Management LLC	19,850	$0.22M	0.0%	N/A	0.040%
8/1/2025	Y Intercept Hong Kong Ltd	40,943	$0.45M	0.0%	N/A	0.082%
7/31/2025	R Squared Ltd	19,976	$0.22M	0.1%	+59.5%	0.040%
7/15/2025	Ballentine Partners LLC	14,315	$0.16M	0.0%	+9.3%	0.029%
7/11/2025	Assenagon Asset Management S.A.	23,980	$0.26M	0.0%	N/A	0.048%
6/18/2025	Voya Investment Management LLC	11,593	$0.10M	0.0%	-11.5%	0.023%
5/29/2025	Rhumbline Advisers	62,254	$0.56M	0.0%	+3.8%	0.125%
5/21/2025	Acadian Asset Management LLC	174,594	$1.55M	0.0%	+121,993.7%	0.349%
5/19/2025	Jane Street Group LLC	140,884	$1.26M	0.0%	+169.2%	0.282%
5/16/2025	Goldman Sachs Group Inc.	210,536	$1.88M	0.0%	-6.5%	0.421%
5/16/2025	Park West Asset Management LLC	1,804,244	$16.11M	1.3%	+0.6%	3.608%
5/16/2025	Jacobs Levy Equity Management Inc.	161,797	$1.45M	0.0%	-63.1%	0.324%
5/16/2025	AQR Capital Management LLC	11,270	$0.10M	0.0%	N/A	0.023%
5/15/2025	PDT Partners LLC	88,577	$0.79M	0.1%	+135.1%	0.177%
5/15/2025	Cubist Systematic Strategies LLC	46,972	$0.42M	0.0%	N/A	0.094%
5/15/2025	State of Wyoming	17,909	$0.16M	0.0%	+36.2%	0.036%
5/15/2025	Trexquant Investment LP	165,424	$1.48M	0.0%	+9.5%	0.331%
5/14/2025	Martingale Asset Management L P	61,330	$0.55M	0.0%	+4.6%	0.123%
5/14/2025	Wellington Management Group LLP	155,429	$1.39M	0.0%	-21.7%	0.311%
5/13/2025	American Century Companies Inc.	85,707	$0.77M	0.0%	+10.0%	0.171%
5/13/2025	Russell Investments Group Ltd.	48,059	$0.43M	0.0%	+118.5%	0.096%

Data available starting January 2016

Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused in the areas of inflammation and immunology. In pursuit of its purpose, Theravance Biopharma applies insights and innovation at each stage of its business and utilizes its internal capabilities and those of partners around the world. The Company applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. These efforts leverage years of experience in developing lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its pipeline of internally discovered programs is targeted to address significant patient needs. Theravance Biopharma has an economic interest in potential future payments from Glaxo Group Limited or one of its affiliates (GSK) pursuant to its agreements with Innoviva, Inc. relating to certain programs, including TRELEGY. For more information, please visit www.theravance.com.

Today's Range

Now: $18.70

$18.59

$19.11

50 Day Range

MA: $15.91

$13.85

$20.31

52 Week Range

Now: $18.70

$7.90

$20.33

Volume

331,231 shs

Average Volume

592,193 shs

Market Capitalization

$947.53 million

P/E Ratio

32.81

Dividend Yield

N/A

Beta

0.14

Who are the company insiders with the largest holdings of Theravance Biopharma?: Theravance Biopharma's top insider shareholders include:
Eli Samaha (Major Shareholder)
Rhonda Farnum (SVP)
Learn More about top insider investors at Theravance Biopharma.
Who are the major institutional investors of Theravance Biopharma?: Theravance Biopharma's top institutional shareholders include:
Vanguard Group Inc. — 4.39%
Park West Asset Management LLC — 2.53%
Dimensional Fund Advisors LP — 1.52%
Arrowstreet Capital Limited Partnership — 1.44%
Bank of America Corp DE — 1.04%
UBS Group AG — 1.02%
Learn More about top institutional investors of Theravance Biopharma stock.
Which major investors are selling Theravance Biopharma stock?: During the last quarter, TBPH stock was sold by these institutional investors:
Park West Asset Management LLC
Citadel Advisors LLC
GSA Capital Partners LLP
Russell Investments Group Ltd.
Aquatic Capital Management LLC
Millennium Management LLC
Barclays PLC
BNP Paribas Financial Markets
Which major investors are buying Theravance Biopharma stock?: In the previous quarter, TBPH stock was acquired by institutional investors including:
Arrowstreet Capital Limited Partnership
Assenagon Asset Management S.A.
Hillsdale Investment Management Inc.
Two Sigma Investments LP
Algert Global LLC
UBS Group AG
JPMorgan Chase & Co.
Man Group plc